|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 203.31 USD | +0.42% |
|
-1.74% | -15.65% |
| 05-11 | Resmed Insider Sold Shares Worth $1,037,233, According to a Recent SEC Filing | MT |
| 05-04 | CSL, Resmed, Cochlear Lead Losses on ASX | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 213.81 | 230.7 | 244.76 |
| Spread/Res. | -4.98% | -11.94% | -16.99% |
| Spread/Supp. | +2.22% | +2.22% | +13.60% |
| Support | 198.76 | 198.76 | 178.85 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- RMD Stock
- Charts ResMed, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition